r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

SR

Simrat Randhawa

Insider · EVP, Head of R&D · DNTH

Simrat Randhawa files insider transactions with the SEC as an evp, head of r&d of Dianthus Therapeutics, Inc. /DE/ (DNTH). We hold 3 disclosed purchases and sales filed since 25 September 2023, 1 of them in the last 90 days.

  • Files forDNTH
  • Disclosed buys and sells3 in all, 1 in the last 90 days
  • Last disclosure3 September 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 21 September 2023 — 1 September 2026EVP, Head of R&D · Dianthus Therapeutics, Inc. /DE/ (DNTH)60 Form 4 lines · source: SEC Form 4

Everything they disclosed

60 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.